SCHEMBL5360488

SCHEMBL5360488

CNCC(N)c1ccc(F)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 2/20 0.41
TAAR1 Q96RJ0 2/20 0.41
SLC6A2 P23975 4/20 0.40
SLC6A4 P31645 4/20 0.40
ADRB1 P08588 1/20 0.40
ADRA2A P08913 1/20 0.40
ADRB3 P13945 1/20 0.40
ADRA2B P18089 1/20 0.40
ADRA2C P18825 1/20 0.40
AOC3 Q16853 2/20 0.39
IDO1 P14902 2/20 0.39
TDO2 P48775 2/20 0.39
ALDH1A1 P00352 1/20 0.38
HTR1A P08908 1/20 0.38
THPO P40225 1/20 0.38
BLM P54132 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NMUR2 Q9GZQ4 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
KDM4E B2RXH2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14143114 0.78 TAAR1 (0.57) DPP4TAAR1SLC6A2SLC6A4AOC3
SCHEMBL24724279 0.78 TAAR1 (0.57) DPP4TAAR1SLC6A2SLC6A4AOC3
SCHEMBL6416831 0.78 SLC6A4 (0.45) TAAR1SLC6A2SLC6A4ADRB1ADRA2A
SCHEMBL8227223 0.78 TAAR1 (0.57) DPP4TAAR1SLC6A2SLC6A4AOC3
SCHEMBL9903509 0.77 SLC6A2 (0.49) TAAR1SLC6A2SLC6A4AOC3GBA1
SCHEMBL5358876 0.77 TAAR1 (0.42) TAAR1SLC6A2SLC6A4ADRB1ADRA2A
SCHEMBL11073428 0.76 GABBR2 (0.50) TAAR1SLC6A2SLC6A4ADRB1ADRA2A
SCHEMBL3343979 0.76 TSHR (0.43) DPP4ALDH1A1
SCHEMBL3343976 0.76 TSHR (0.43) DPP4ALDH1A1
SCHEMBL1364755 0.76 SLC6A4 (0.57) DPP4SLC6A4AOC3IDO1TDO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7217723-B2 Substituted benzothiophenes, e.g., 7Z)-7-hydroxyimino-4,5,6,7-tetrahydro-benzo[b]thiophene-3-sulfonic acid [2-(4-fluorophenyl)-2-hydroxyethyl]-methyl-amide; treating allergies such as atopic dermatitis, allergic coryza, bronchial asthma, hypersensitive pneumoniac and pulmonary aspergillosis. EISAI CO., LTD. (JP) 2007-05-15 US disclosed
US-20050227959-A1 Heterocyclic compound having oxime group EISAI CO., LTD. (JP) 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050227959-A1 Heterocyclic compound having oxime group STAT6, HRH4, HRH2 DPP4 2607/4885TAAR1 675/4885SLC6A2 4708/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.